Cambridge Investment Research Advisors
TBI

Cambridge Investment Research Advisors’s Trueblue TBI Stock Holding History

Cambridge Investment Research Advisors’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-29,101
Closed -$647K – 2351
2018
Q4 		$647K Buy
29,101
+1,661
+6% +$39.8K 0.01% 1182
2018
Q3 		$715K Buy
27,440
+125
+0.5% +$3.47K 0.01% 1234
2018
Q2 		$736K Buy
27,315
+759
+3% +$20.1K 0.01% 1174
2018
Q1 		$688K Buy
+26,556
New +$726K 0.01% 1150

Other funds holding TBI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cambridge Investment Research Advisors's TBI Position: Q1 2019 in Review

Cambridge Investment Research Advisors sold out of Trueblue (TBI) in Q1 2019, closing a stake of 29,101 shares — an estimated $647K sold.

Cambridge Investment Research Advisors first reported a position in TBI in Q1 2018 and held it in 4 quarters. The position peaked at $736K in Q2 2018. 191 funds tracked by Wall St. Rank hold TBI as of Q1 2019.

  • Cambridge Investment Research Advisors reported no remaining Trueblue position as of Q1 2019 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 29,101 Trueblue shares in Q1 2019, an estimated $647K.
  • Cambridge Investment Research Advisors first reported a position in Trueblue in Q1 2018 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Trueblue position peaked at $736K in Q2 2018.
  • 191 funds tracked by Wall St. Rank held Trueblue as of Q1 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2019, filed 8 May 2019.